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Rabies is one of the oldest zoonotic disease which continues
to pose a signiﬁcant threat to humans in most parts of
the world, particularly in Asia and Africa. As huge animal
reservoirs exist in most parts of the world, the threat to
humans is likely to continue for many more years. In the
past decade, a renewed eﬀort has been made to reduce the
burden of rabies focusing particularly on the Asian and
African countries. Several national and international orga-
nizations including World Health Organization (WHO) and
Global Alliance for rabies Control (GARC) are now actively
working out various strategies for getting international and
national commitment to eliminate human rabies and reduce
canine rabies. New developments have taken place in rabies
prevention in humans and canine rabies control. Keeping
this view, a special issue of Journal of Preventive Medicine
was designed to update the readers on important aspects
of rabies prevention, epidemiology and control. There are
six well written and informative papers in this issue. The
ﬁrst paper by G. Gongal and A. E. Wright deals with the
current rabies scenario in the world with special reference
to south east Asian countries which contribute nearly 60%
of global burden. The paper describes the current trends in
human and animal rabies in this region and newly initiated
preventive and control eﬀorts to eliminate dog-mediated
humanrabiesinthisregion.ThesecondpaperbyB.Dodetet
al. gives an insight into the rabies situation in eastern Europe
and Middle East. The paper deals with the outcome of a
meeting of these countries which have recently joined hands
in forming a Middle East and Eastern Europe Rabies Expert
Bureau (MEEREB). It highlights the continued presence of
caninerabiesparticularlyinEgypt,Turkey,Iran,andUkraine
where several human deaths have occurred. The number
of postexposure treatments is also on the increase in these
countries Iran alone is administering more than 200,000
PEPs to humans bitten by dogs.
The third paper by J. M. Reynes et al. describes a
collaborative study between Pasteur Institute, Madagascar
and Pasteur Institute, Paris on the situation of rabies in
humans and animals in the island country of Madagascar
located in the Indian Ocean in the eastern coast of Africa.
The study analyses the rabies situation between 2005 and
2010 and the incidence of canine rabies was 54% and 9
conﬁrmed human deaths occurred. Interestingly, rabies was
not reported in bat species though one bat species did had
antibodies to Lyssavirus.
Though intradermal rabies vaccination (IDRV) with
m o d e r nc e l lc u l t u r er a b i e sv a c c i n e si sn o ww i d e l yu s e di n
many developing countries, the minimum potency require-
ment for IDRV is not very well documented and some
countries have opted for a higher antigenicity (>2.5IU per
intramuscular dose). In an interesting study reported here
by D. Brown et al. from the UK, it is clear that 100%
seroconversion with antibody titers equal to or greater
than 0.5IU/mL can be achieved if a minimum cumulative
antigenic content administered over a period is at least 2IU.
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of subjects and a larger study of this kind may help us
understand the kinetics of immune response to varying
antigenic content and dosage schedule of IDRV.
Another interesting observation with regard to IDRV has
been reported by T. Kamoltham et al. from Thailand. Here,
they have compared the anamnestic response to booster
doses of vaccine in school children who had received 2 (day
0 and 28) or 3 doses (days 0, 7, and 28) of preexposure
primary vaccination in the past. They have shown that 2
doses by themselves induced protective levels of antibodies
and the anamnestic response to booster doses administered
1, 3, or 5 years later was more or less, the same both
in 2-dose and 3-dose primary groups. This aspect needs
further investigation, as it has some implication in the cost
of preexposure vaccination in children in rabies endemic
countries.
Inrecentyears,moreandmoreinformationhasaccumu-
lated on the structure and functions of rabies phosphopro-
tein(P).Ithasbeenshownthatitisinvolvedintheinduction
of innate immunity by promoting interferon production.
Some groups are targeting P for genetic alteration and
creating eﬀective live attenuated vaccines for animal use. In
a very interesting study, A. Vos et al. from Germany have
created a P gene deletion mutant of SAD B 19 strain of rabies
virus that seems to have a potential for use as live attenuated
virus for immunization of animals. Such studies are indeed
required to produce live vaccines that are not only highly
immunogenic but also safe for untargeted animal species,
specially humans.
Over all, this special issue on rabies contains timely,
informative, and thought-provoking papers that may be of
interest not only to basic researchers but also to medical
andveterinaryprofessionalsengagedinpreventionofhuman
rabies and control of canine rabies.
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